{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:52:56Z","timestamp":1791499976518,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016380","name":"Bispebjerg Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jdin.2024.03.002","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T08:59:11Z","timestamp":1710493151000},"page":"170-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4616-5188","authenticated-orcid":false,"given":"Nikolaj","family":"Holgersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdemar Wendelboe","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana Aviaaja Lippert","family":"Rosen\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob P.","family":"Thyssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Egeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe Holm","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Christian","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Francis","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jdin.2024.03.002_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jdin.2024.03.002_bib2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaad.2019.08.090","article-title":"Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis","volume":"82","author":"Goldburg","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jdin.2024.03.002_bib3","first-page":"17","article-title":"Hidradenitis suppurativa: causes, features, and current treatments","volume":"11","author":"Vinkel","year":"2018","journal-title":"J Clin Aesthet Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.03.002_bib4","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/bjd.19435","article-title":"The epidemiology of hidradenitis suppurativa","volume":"183","author":"Ingram","year":"2020","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2024.03.002_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/jdv.16677","article-title":"Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life","volume":"35","author":"Nguyen","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jdin.2024.03.002_bib6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jdin.2024.03.002_bib7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa","volume":"70","author":"Gold","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jdin.2024.03.002_bib8","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamadermatol.2014.1165","article-title":"Association of metabolic syndrome and hidradenitis suppurativa","volume":"150","author":"Miller","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"10","key":"10.1016\/j.jdin.2024.03.002_bib9","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/ijd.15910","article-title":"Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects","volume":"61","author":"Mintoff","year":"2022","journal-title":"Int J Dermatology"},{"issue":"4","key":"10.1016\/j.jdin.2024.03.002_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","article-title":"Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2024.03.002_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamadermatol.2019.3412","article-title":"Incidence of myocardial infarction and cerebrovascular accident in patients with hidradenitis suppurativa","volume":"156","author":"Reddy","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2024.03.002_bib12","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/bjd.14024","article-title":"Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies","volume":"173","author":"Tzellos","year":"2015","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.jdin.2024.03.002_bib13","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.3390\/ijms24098414","article-title":"Assessing the relationship between systemic immune-inflammation index and metabolic syndrome in children with obesity","volume":"24","author":"Nicoar\u0103","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jdin.2024.03.002_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1076029612459675","article-title":"Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome","volume":"20","author":"Buyukkaya","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"10.1016\/j.jdin.2024.03.002_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12902-023-01369-4","article-title":"The neutrophil to lymphocyte ratio (NLR) positively correlates with the presence and severity of metabolic syndrome in obese adults, but not in obese children\/adolescents","volume":"23","author":"Marra","year":"2023","journal-title":"BMC Endocr Disord"},{"issue":"6","key":"10.1016\/j.jdin.2024.03.002_bib16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/15622975.2021.2013089","article-title":"Association between neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and C-reactive protein levels and metabolic status in patients with a bipolar disorder","volume":"23","author":"Sanchez-Autet","year":"2022","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.jdin.2024.03.002_bib17","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.2147\/JIR.S375759","article-title":"Relationship between monocyte-to-lymphocyte ratio as well as other leukocyte-derived ratios and carotid plaques in patients with coronary heart disease: a RCSCD-TCM study","volume":"15","author":"Ma","year":"2022","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jdin.2024.03.002_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.952953","article-title":"Association of the systemic immune-inflammation index with all-cause mortality in patients with arteriosclerotic cardiovascular disease","volume":"9","author":"He","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.jdin.2024.03.002_bib19","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3390\/jcm12031128","article-title":"Systemic immune inflammation index (SII), system inflammation response index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42,875 US adults","volume":"12","author":"Xia","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jdin.2024.03.002_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2021.02.012","article-title":"Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: the Dongfeng-Tongji cohort study","volume":"323","author":"Xu","year":"2021","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.jdin.2024.03.002_bib21","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/eurheartj\/ehaa1034","article-title":"The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials","volume":"42","author":"Adamstein","year":"2021","journal-title":"Eur Heart J"},{"issue":"9709","key":"10.1016\/j.jdin.2024.03.002_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jdin.2024.03.002_bib23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00403-015-1596-5","article-title":"Patients with hidradenitis suppurativa carry a higher systemic inflammatory load than other dermatological patients","volume":"307","author":"Riis","year":"2015","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"10.1016\/j.jdin.2024.03.002_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14835","article-title":"Evaluation of the laboratory parameters in hidradenitis suppurativa: can we use new inflammatory biomarkers?","volume":"34","author":"\u00c7etinarslan","year":"2021","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.jdin.2024.03.002_bib25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1159\/000446021","article-title":"Leukocyte profile in peripheral blood and neutrophil-lymphocyte ratio in hidradenitis suppurativa: a comparative cross-sectional study of 462 cases","volume":"232","author":"Miller","year":"2016","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.jdin.2024.03.002_bib26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/bjd.17716","article-title":"Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa","volume":"181","author":"Thorlacius","year":"2019","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2024.03.002_bib27","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/bjd.15748","article-title":"Development and validation of the International Hidradenitis Suppurativa severity score system (IHS4), a novel dynamic scoring system to assess HS severity","volume":"177","author":"Zouboulis","year":"2017","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2024.03.002_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000431175","article-title":"Hidradenitis suppurativa\/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation","volume":"231","author":"Zouboulis","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.jdin.2024.03.002_bib29","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/jvc2.222","article-title":"Psychiatric co-morbidity in patients with hidradenitis suppurativa: a cross-sectional study of clinical characteristics and burden of disease","volume":"2","author":"Holgersen","year":"2023","journal-title":"JEADV Clinical Practice"},{"issue":"2","key":"10.1016\/j.jdin.2024.03.002_bib30","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"24","author":"Grundy","year":"2004","journal-title":"ATVB"},{"issue":"9491","key":"10.1016\/j.jdin.2024.03.002_bib31","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2014a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jdin.2024.03.002_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinf"},{"issue":"9","key":"10.1016\/j.jdin.2024.03.002_bib33","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/jdv.18175","article-title":"Complete blood collection-based systemic inflammation biomarkers for patients with hidradenitis suppurativa","volume":"36","author":"Gambichler","year":"2022","journal-title":"Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.jdin.2024.03.002_bib34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/ijd.16744","article-title":"The role of new inflammatory markers in determining disease activation and severity in patients with hidradenitis suppurativa","volume":"62","author":"\u00d6ks\u00fcm Solak","year":"2023","journal-title":"Int J Dermatology"},{"issue":"4","key":"10.1016\/j.jdin.2024.03.002_bib35","first-page":"352","article-title":"Systemic immune-inflammation index (SII) predicts increased severity in psoriasis and psoriatic arthritis","volume":"46","author":"Yorulmaz","year":"2020","journal-title":"Curr Health Sci J"},{"issue":"6","key":"10.1016\/j.jdin.2024.03.002_bib36","doi-asserted-by":"crossref","first-page":"e14101","DOI":"10.1111\/ijcp.14101","article-title":"The utility of systemic-immune inflammation index for predicting the disease activation in patients with psoriasis","volume":"75","author":"Dincer Rota","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"11","key":"10.1016\/j.jdin.2024.03.002_bib37","doi-asserted-by":"crossref","first-page":"e928","DOI":"10.1111\/jdv.18322","article-title":"Systemic immune inflammation index is a marker of cardiovascular risk and not just disease severity in hidradenitis suppurativa","volume":"36","author":"Kearney","year":"2022","journal-title":"Acad Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.jdin.2024.03.002_bib38","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/1346-8138.16558","article-title":"Exploring the role of systemic immune-inflammation index and neutrophil-lymphocyte ratio in cardiovascular risk stratification for patients with hidradenitis suppurativa: a cross-sectional study","volume":"49","author":"S\u00e1nchez-D\u00edaz","year":"2022","journal-title":"J Dermatol"},{"issue":"7","key":"10.1016\/j.jdin.2024.03.002_bib39","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3390\/jpm12071180","article-title":"Cardiovascular risk prediction models and scores in the era of personalized medicine","volume":"12","author":"Sofogianni","year":"2022","journal-title":"J Pers Med"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328724000397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328724000397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T17:44:58Z","timestamp":1717436698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328724000397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":39,"alternative-id":["S2666328724000397"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2024.03.002","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2024.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}